Most lately, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger https://samuelg515yme6.wikimidpoint.com/user